# Module_5_Challenge -Pymaceuticals

# Challenge
As a senior data analyst at the company, you've been given access to the complete data from their most recent animal study. In this study, 249 mice who were identified with SCC tumors received treatment with a range of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, against the other treatment regimens.

The purpose of this activity is to generate all of the tables and figures needed for the technical report of the clinical study, including a high-level summary of the study results.

The following visuals were generated: 

#Display Summary Stats Table 

